Lite Strategy Stock Market Value
| LITS Stock | 1.30 0.00 0.00% |
| Symbol | Lite |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lite Strategy. If investors know Lite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lite Strategy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lite Strategy is measured differently than its book value, which is the value of Lite that is recorded on the company's balance sheet. Investors also form their own opinion of Lite Strategy's value that differs from its market value or its book value, called intrinsic value, which is Lite Strategy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lite Strategy's market value can be influenced by many factors that don't directly affect Lite Strategy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lite Strategy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lite Strategy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lite Strategy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lite Strategy 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lite Strategy's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lite Strategy.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Lite Strategy on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Lite Strategy or generate 0.0% return on investment in Lite Strategy over 90 days. Lite Strategy is related to or competes with Tscan Therapeutics, Adicet Bio, Immunic, Pmv Pharmaceuticals, Relmada Therapeutics, Nutriband, and Acrivon Therapeutics. Lite Strategy is entity of United States More
Lite Strategy Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lite Strategy's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lite Strategy upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 26.34 | |||
| Value At Risk | (9.52) | |||
| Potential Upside | 7.73 |
Lite Strategy Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lite Strategy's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lite Strategy's standard deviation. In reality, there are many statistical measures that can use Lite Strategy historical prices to predict the future Lite Strategy's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.06) | |||
| Treynor Ratio | (0.21) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lite Strategy's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lite Strategy January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.20) | |||
| Mean Deviation | 4.48 | |||
| Coefficient Of Variation | (1,133) | |||
| Standard Deviation | 5.76 | |||
| Variance | 33.19 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.06) | |||
| Treynor Ratio | (0.21) | |||
| Maximum Drawdown | 26.34 | |||
| Value At Risk | (9.52) | |||
| Potential Upside | 7.73 | |||
| Skewness | 0.4605 | |||
| Kurtosis | 0.2855 |
Lite Strategy Backtested Returns
Lite Strategy has Sharpe Ratio of -0.0838, which conveys that the firm had a -0.0838 % return per unit of risk over the last 3 months. Lite Strategy exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lite Strategy's Mean Deviation of 4.48, risk adjusted performance of (0.06), and Standard Deviation of 5.76 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 2.45, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lite Strategy will likely underperform. At this point, Lite Strategy has a negative expected return of -0.48%. Please make sure to verify Lite Strategy's total risk alpha and rate of daily change , to decide if Lite Strategy performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.16 |
Very weak predictability
Lite Strategy has very weak predictability. Overlapping area represents the amount of predictability between Lite Strategy time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lite Strategy price movement. The serial correlation of 0.16 indicates that over 16.0% of current Lite Strategy price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.16 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Lite Stock Analysis
When running Lite Strategy's price analysis, check to measure Lite Strategy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lite Strategy is operating at the current time. Most of Lite Strategy's value examination focuses on studying past and present price action to predict the probability of Lite Strategy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lite Strategy's price. Additionally, you may evaluate how the addition of Lite Strategy to your portfolios can decrease your overall portfolio volatility.